New urine test shows promising results in detecting, classifying risk for prostate cancer

A newly published article in BJU International has described a way to test post-DRE urine samples for the presence of specific types of ribonucleic acid (RNA) and use these data to detect and classify risk levels for more and less aggressive forms of prostate cancer. … READ MORE …

Getting closer to diagnosing prostate cancer “by a sniff test”

Yet another research group is presenting data this week (at a meeting of the American Chemical Society) on the potential to identify risk for prostate cancer based on smell. … READ MORE ….

The newly available, urine-based ExoDx Prostate(IntelliScore) test

Back in April this year we reported on the publication of an article in JAMA Oncology that gave information about the development of a new test for risk of clinically significant prostate cancer — a test that could be conducted using a simple urine sample. … READ MORE …

A new urine test to assess risk for prostate cancer?

Apparently a newly developed type of urine test — an RNA-based “urine exosome gene expression assay” — has the potential to differentiate between risk for high-grade prostate cancer (Gleason score ≥ 7) and low-grade prostate cancer (Gleason score 6) or benign disease. … READ MORE …

Liu and Zoey “are Ferraris” who massively outperform PSA testing

A report on the Medscape Oncology site on Tuesday discussed prostate cancer detection data presented at the annual meeting of the American Urological Association (AUA) by a group of Italian researchers — with the help of two highly trained German Shepherds. … READ MORE …

Diagnosis of prostate cancer with an “eNose”: is this real?

For those of you who remember media reports and scientific papers showing that some cancers (prostate cancer included) could be detected, albeit with limited consistency, in urine samples by trained dogs … yes, this is now getting closer to real. … READ MORE …

New urine-based test may be able to eliminate need for biopsy in many patients

A new report giving preliminary data on the clinical performance of novel, urine-based prostate cancer assay uses a method known as prostate-specific antigen/solvent interaction analysis (PSA/SIA) to detect the ratios of different types of PSA (PSA “isoforms”) in the urine of men beleived to be at risk for prostate cancer. … READ MORE …